<?xml version="1.0"?>
<npl:medprod xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mpa="urn:schemas-npl:mpa:12" xsi:schemaLocation="urn:schemas-npl:instance:12 ../schemas/npl-schema_12.0.xsd" xmlns:npl="urn:schemas-npl:instance:12">
  <mpa:nplid>20190913000014</mpa:nplid>
  <npl:approvalnumber>
    <mpa:semano>597210</mpa:semano>
    <mpa:eumano>EU/1/20/1512</mpa:eumano>
  </npl:approvalnumber>
  <npl:names>
    <mpa:medprodname v="Abiraterone Accord" />
    <mpa:medprodnamelegal v="Abiraterone Accord" />
  </npl:names>
  <mpa:strength-text>
    <mpa:v>250 mg</mpa:v>
  </mpa:strength-text>
  <mpa:pharmaceutical-form-lx v="TABLET" lexicon="pharmaceutical-form-lx" />
  <npl:organizations>
    <mpa:organization>
      <mpa:organization-lx v="ID12TSM4H13QAIROSR" />
      <mpa:organization-role-lx v="AGENT" lexicon="organization-role-lx" />
    </mpa:organization>
    <mpa:organization>
      <mpa:organization-lx v="IDPRFRNH18YHTT6SRV" />
      <mpa:organization-role-lx v="MAH" lexicon="organization-role-lx" />
    </mpa:organization>
  </npl:organizations>
  <mpa:approvaldate>2021-04-26</mpa:approvaldate>
  <mpa:productclass-lx v="MEP" lexicon="productclass-lx" />
  <mpa:prescription-lx v="1" lexicon="prescription-lx" />
  <npl:classifications>
    <mpa:atc-code-lx v="L02BX03" />
    <mpa:controlled-medicinal-product-lx v="N" lexicon="yesno-lx" />
    <mpa:narcotic-class-lx v="0" lexicon="narcotic-classification-lx" />
  </npl:classifications>
  <mpa:authorisation-procedure-lx v="2" lexicon="authorisation-procedure-lx" />
  <npl:flags>
    <mpa:salesstopped v="N" lexicon="yesno-lx" />
    <mpa:biological-medprod-pharmaceutical-legislation v="N" lexicon="yesno-lx" />
    <mpa:antimicrobial v="N" lexicon="yesno-lx" />
    <mpa:reserved-hum v="N" lexicon="yesno-lx" />
  </npl:flags>
  <npl:pharmaceutical-products>
    <npl:pharmaceutical-product id="ID4JN8LRYWH05TSRV0">
      <npl:composition>
        <npl:ingredient id="ID4JN8LSYWH0M9SRV0" presentation-substance-name="Y" substance-for-reference-strength="Y">
          <mpa:ingredient-role-lx v="ACTI" lexicon="ingredient-role-lx" />
          <mpa:quantity v="250" />
          <mpa:quantity-unit-lx v="03" lexicon="quantity-unit-lx" />
          <mpa:quantity-unit-alt-lx v="EQ" lexicon="quantity-unit-alt-lx" />
          <mpa:substance-lx v="IDL68GFT1D4LRK2SRV" />
        </npl:ingredient>
        <npl:ingredient id="ID82GNIU3INGGFSRV0">
          <mpa:ingredient-role-lx v="MISC" lexicon="ingredient-role-lx" />
          <mpa:substance-lx v="IDE4POI8UC9O7VERT1" />
        </npl:ingredient>
        <npl:ingredient id="ID82GNO33IPSB3SRV0">
          <mpa:ingredient-role-lx v="MISC" lexicon="ingredient-role-lx" />
          <mpa:substance-lx v="IDE4POC7U9C0ZVERT1" />
        </npl:ingredient>
      </npl:composition>
      <mpa:comp-ref-quantity-lx v="FGE" lexicon="comp-ref-quantity-lx" />
    </npl:pharmaceutical-product>
  </npl:pharmaceutical-products>
  <npl:interchangeability>
    <mpa:interchange-strength-group id="5485" start-date="2021-06-30" lexicon="interchange-strength-group" />
  </npl:interchangeability>
  <npl:packages>
    <npl:package>
      <mpa:nplpackid>20191129100178</mpa:nplpackid>
      <mpa:pack-eumano>EU/1/20/1512/001</mpa:pack-eumano>
      <mpa:pack-text>
        <mpa:v>Burk, 120 tabletter</mpa:v>
      </mpa:pack-text>
      <npl:prescription>
        <mpa:otc v="N" lexicon="yesno-lx" />
      </npl:prescription>
      <mpa:safety-features v="Y" lexicon="yesno-lx" />
      <npl:storage>
        <mpa:pack-condition-lx v="1" lexicon="pack-condition-lx" id="ID82GSAS3JFIZRSRV0" pharmaceutical-product-id="ID4JN8LRYWH05TSRV0">
          <mpa:shelf-life v="2">
            <mpa:shelf-life-unit-lx v="5" lexicon="shelf-life-unit-lx" />
            <mpa:storage-temp-lx v="1" lexicon="storage-temp-lx" />
          </mpa:shelf-life>
        </mpa:pack-condition-lx>
      </npl:storage>
    </npl:package>
  </npl:packages>
</npl:medprod>
